Hutch News
Infections in immune-compromised patients: 5 new frontiers
Infectious disease experts gather in Seattle to find solutions for patients with compromised immunity
First systematic study of infections after CAR T-cell therapy
“Benchmark” research could help reduce complications of emerging immunotherapy
Good News: Drs. Grzelak, Anderson get Komen awards; Infectious Disease Sciences earns training grant; Drs. Bloom, Matsen named HHMI-Simons Faculty Scholars
Celebrating faculty and staff achievements
Good News at Fred Hutch
Researchers led by Dr. Ulrike Peters identify six new gene locations for colorectal cancer risk; Drs. Tera Levin and Alistair Russell named Damon Runyon Fellows
Ebola lessons applied to vaccine clinical trials
3 proposals for ‘thinking outside the box’ in public health emergencies
When the doctor is the patient
A kidney transplant and a cancer diagnosis helped shape the career of infection-control expert Steve Pergam
Unraveling the mystery of BV
Scientists in Fredricks' lab detect bacterial species that may cause complications associated with common vaginal infection
HVTN, Merck launch HIV-vaccine trial
'Proof of concept' study involves vaccine candidate designed to generate a cellular immune response that may offer protection against HIV or delay or diminish the course of HIV infection